Atom | Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies

Due Dates: May 28, 2025 (Letter of Intent) | July 16, 2025 (Full Proposal)

Funding Amounts: Up to $600,000 total over 2 years (including 10% indirects for nonprofits); industry terms differ.

Summary: Funding for academic and industry projects developing technologies to scale and improve manufactured islet cell therapies for type 1 diabetes.

Key Information: LOI required; both academic and industry applicants eligible; focus on scalability and GMP-compatible solutions.

Breakthrough T1D Request for Applications: Supportive Technologies for the Scaling of Manufactured Islet Replacement Therapies

Sign in to see full grant listing